Skip to content

Royalty Pharma plc Class A Ordinary Shares (RPRX) — DCF Valuation Summary

Based on a DCF model, Royalty Pharma plc Class A Ordinary Shares (RPRX) has an estimated fair value of $181.38, compared to a current price of $58.43.

Model Assumptions & Verdict

Using a WACC of 6.2%, a terminal growth rate of 2.5%, and projected FCF growth of 5.1%, the model suggests RPRX is currently undervalued with upside/downside of +210.4% versus the current price.

Verdict: Undervalued — Upside / Downside: +210.4%

DeepViews
VALUATION

DCF Valuation Calculator

[01]
Enter Company Ticker
Quick search:
Model Inputs & Results
[02]DCF Assumptions

Growth Stage

Rate declines linearly to terminal rate over projection period

$0

Negative or zero FCF — DCF model is not applicable. Enter a positive value or use alternative valuation methods.

10.0%
-10%40%

Terminal Stage

Perpetuity growth after projection period

2.5%
0%5%
10.0%
4%20%
$0
0.00B

Search for a company to start DCF analysis

Enter a ticker symbol and data will auto-populate into the model

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.